Related Experiment Video

Updated: Aug 18, 2026

Establishing a Swine Model of Post-myocardial Infarction Heart Failure for Stem Cell Treatment
08:24

Establishing a Swine Model of Post-myocardial Infarction Heart Failure for Stem Cell Treatment

Published on: May 25, 2020

The management of heart failure in Sweden

C M J Cline1, K Boman, M Holst

  • 1Department of Cardiology, Malmö University Hospital, Lund University, SE-205 02, Malmö, Sweden. charles.cline@medforsk.mas.lu.se

European Journal of Heart Failure
|May 30, 2002
PubMed

Insights

Heart failure affects over 160,000 Swedes, posing a significant healthcare burden. Adherence to guidelines and access to echocardiography in primary care are suboptimal, necessitating improved management strategies.

Area of Science:

  • Cardiology
  • Public Health
  • Healthcare Management

Background:

  • Heart failure (HF) is a growing concern in Sweden, impacting over 160,000 individuals and incurring substantial healthcare costs (SEK 2.5 billion annually).
  • HF is a leading cause of hospitalization for individuals over 65, highlighting its significant impact on the elderly population.
  • Current management faces challenges including inconsistent adherence to national guidelines and limited access to diagnostic tools in primary care settings.

Purpose of the Study:

  • To assess the current landscape of heart failure diagnosis and treatment within the Swedish healthcare system.
  • To identify key challenges and areas for improvement in heart failure management, particularly concerning guideline adherence and resource accessibility.
  • To evaluate the emerging role of nurse-led heart failure clinics in addressing cost and care quality.

Main Methods:

  • Review of current diagnostic and treatment practices for heart failure in Sweden.
  • Analysis of healthcare costs associated with heart failure management.
  • Examination of the utilization rates of diagnostic tools like echocardiography in primary care versus hospital settings.
  • Assessment of the prescription patterns for key heart failure medications, such as ACE inhibitors and beta-blockers.

Main Results:

  • Echocardiography utilization is significantly lower in primary care (approx. 30%) compared to hospitals, likely due to access issues.
  • Under-prescription of Angiotensin-converting enzyme (ACE) inhibitors and beta-blockers is observed.
  • National diagnostic and treatment guidelines are not universally followed.
  • Nurse-led heart failure clinics are increasingly being established to manage costs and enhance patient care.

Conclusions:

  • There are significant gaps in adherence to heart failure guidelines and suboptimal use of diagnostic tools in Swedish primary care.
  • Improved access to echocardiography and better adherence to evidence-based pharmacotherapy are crucial for enhancing heart failure management.
  • The expansion of nurse-led clinics represents a promising strategy for cost containment and improved quality of care in heart failure management.

More Related Videos

Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs14:35

Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs

Published on: April 17, 2021

A Surgical Model of Heart Failure with Preserved Ejection Fraction in Tibetan Minipigs07:09

A Surgical Model of Heart Failure with Preserved Ejection Fraction in Tibetan Minipigs

Published on: February 18, 2022

Related Concept Videos

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Heart Failure VII: Nursing Interventions01:30

Heart Failure VII: Nursing Interventions

The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...